Strategic partnerships Latica is actively expanding via collaborations in healthcare research and GI follow-on initiatives, evidenced by recent ties with Gastro Girl Inc. and the American Gastroenterological Association. This signals ongoing interest from health systems and research bodies in real-world evidence platforms, presenting upsell opportunities for expanded data collaboration and higher-tier analytics.

Real‑world evidence The company focuses on real-world clinical data and AI-driven research solutions, with recent engagements that emphasize real-world evidence studies. This aligns with pharma, device developers, and research institutions seeking observational data and actionable insights to accelerate clinical programs and regulatory submissions.

GI market momentum Notable integration with Capital Digestive Care and GI-focused initiatives point to a strong foothold in gastroenterology. This niche positioning suggests cross-sell potential to GI-focused health systems, CROs, and biotech players pursuing GI therapy innovations and diagnostics.

Secure data platform Latica emphasizes HIPAA-compliant, secure, and privacy-first data collaboration. This security posture resonates with providers and life sciences organizations handling sensitive clinical and operational data, presenting opportunities for enterprise-scale deployments and managed data sharing agreements.

Growing revenue base With reported revenue in the mid-range of tens of millions and a lean team size, Latica may be open to tiered expansion, higher ACV contracts, and expansion into adjacent data domains. This creates potential for upsell to broader data ecosystems, additional modules, and premium support offerings.